What We Do
Who We Are
Simulations
Presentations & Research
Contact Us
White Paper
Disclaimer
Industry Sector
Global Region
ETF's and Futures
Major Funds - Holding
Tutorial
Best Risk Adjusted
Worst Risk Adjusted
Best Expected
Worst Expected
Sector Ranking
Dividend
REIT's
Leverage Risk
Convertible Bonds
Investment Grade
High Yield
ADR
Small Caps
Rational Investing
About Us
arrow_drop_down
Coverage
arrow_drop_down
Returns
arrow_drop_down
Product
arrow_drop_down
Drug Manufacturers - Other
Total Market Capitalization of All Firms
109081 mm
Average Market Capitalization
18180 mm
Average Market to Model Ratio Weighted by Log of Market Cap
0.87
Standard Deviation of MM Ratio
0
Average Beta
1.06
Average EV To Revenue
4.31
Average Price To Free Cash Flow
70.46
Ticker
Company Name
Market To Model
Market Cap ($ mm)
EV to Revenue
Price To FCF
% Growth
Beta
As Of
BAYN.DE
BAYER AG
1.3
71,372
2.9
-10.4
8
1.10
Sep 19
BHC
Bausch Health
1.3
10,187
4.0
4.6
3
0.90
Sep 19
BMRN
Biomarin Pharmaceutical Inc.
0.8
14,340
9.2
333.9
11
1.25
Sep 19
VRX
Valeant Pharmaceuticals Intern
0.6
8,140
3.8
4.4
5
0.78
Mar 18
ENDP
Endo Pharmaceuticals Holdings
0.5
1,090
3.5
1.3
-3
1.34
Sep 19
UTHR
United Therapeutics Corp
0.5
3,953
2.6
8.1
1
0.96
Sep 19
Standard Value
|
About us
|
Contact us
    Copyright © 2003-2019 Rational Investing LLC ® | All Rights Reserved